Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide versus risedronate after recent pertrochanteric hip fracture
2008-002693-35Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in osteoporosis and osteopenia comparing Teriparatide with Risedronate (2 arms). Started Oct 2008; status: completed.
02
Drugs
teriparatiderisedronate
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on 2008-002693-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002693-35.